Randomized phase 2 trial of the Vincristine-Irinotecan combination with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: an EpSSG/ITCC trial.
| dc.contributor.author | Chisholm, J | |
| dc.date.accessioned | 2021-07-13T15:19:08Z | |
| dc.date.available | 2021-07-13T15:19:08Z | |
| dc.identifier.citation | Journal of Clinical Oncology | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4684 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | American Society of Clinical Oncology | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
| dc.title | Randomized phase 2 trial of the Vincristine-Irinotecan combination with or without Temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: an EpSSG/ITCC trial. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2021-06-17 | |
| rioxxterms.version | AM | |
| rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
| rioxxterms.licenseref.startdate | 2021-06-17 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Journal of Clinical Oncology | |
| pubs.notes | No embargo | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials in Children and Young People/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Clinical Trials in children and young people/Sarcoma Clinical Trials in Children and Young People (hon.) | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Accepted | |
| pubs.embargo.terms | No embargo | |
| icr.researchteam | Sarcoma Clinical Trials in children and young people | |
| icr.researchteam | Sarcoma Clinical Trials in children and young people | |
| dc.contributor.icrauthor | Chisholm, Julia |
Files in this item
This item appears in the following collection(s)
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0